The global scar treatment market is witnessing significant growth due to rising prevalence of skin disease and growing expenditure on personal care. Moreover, technological advancements in scar treatment and increasing appearance consciousness among consumers are also driving the growth of the market. However, high costs of advanced scar treatments and side effects of various treatments inhibits the growth of the market. The scar treatment market is anticipated to grow from an estimated US$ 16,048.7 Mn in 2015 to US$ 31,904.8 Mn by 2022 at a CAGR of 10.3% during the forecast period.
According to a new market report published by Persistence Market Research “Global Market Study on Scar Treatment: Asia to Witness Highest Growth by 2022”, the global scar treatment market is estimated to account for US$ 16,048.7 Mn by the end of 2015. The market is expected to expand at a CAGR of 10.3% from 2015 to 2022, accounting for US$ 31,904.8 Mn by 2022.
Merz Pharma GmbH & Co. KGaA, Pacific World Corporation, Oculus Innovative Sciences, Inc., Valeant Pharmaceuticals International Inc., Avita Medical Limited, Enaltus, LLC., Revitol Corporation Inc., Scarguard Labs LLC, Quantum, Inc., CCA industries Inc. are some of the major players of Global Scar Treatment Market.
Request Sample Report @ https://www.persistencemarketresearch.com/samples/3471